'
Shalby hosted a
conference call on Oct 30, 2023. In the conference call the company was
represented by- Dr. Vikram Shah, Chairman and Managing Director, Mr. Sushobhan Dasgupta, Vice Chairman &
Global President, Mr. Shanay Shah,
President and Mr. Amit Pathak, Chief Financial Officer.
Key takeaways of the call
Company’s hospital
business revenue grew by 22% YoY in Q2 FY23.
In Q2 FY24, Arthroplasty
contributed 42% to total revenue, Critical Care & General Medicine 11%,
Cardiac Science 8%, Oncology 11%, Orthopaedic 7%, Neurology 5%, Nephrology 5%
and Others 12%.
Company is well
placed to achieve double-digit growth in the hospital sector while maintaining
consistent profitability driven by launch of new products, increase in new
accounts, and addition of new territories.
Company’s core
specialties like Arthroplasty, Oncology, Cardiac Science, Orthopedi...
Pleaselogin & subscribe to view the full report.
More Reports
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
Targets revenue of Rs 1000 crore in FY24
-
Capex plan is US$ 30-32 million for next three years
-
Company plans capex of Rs 10,000 crore over the next three years to create growth vectors
|
|